Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential

FEBS Letters

Volumn 579, Issue 10, 2005, Pages 2130-2136

  Lu, Wei ^a   Wu, Xiao Dong ^a   Shi, Mu De ^a   Yang, Rui Fu ^c   He, You Yu ^b   Bian, Chao ^a   Shi, Tie Liu ^b   Yang, Sheng ^a   Zhu, Xue Liang ^a   Jiang, Wei Hong ^a   Li, Yi Xue ^b   Yan, Lin Chen ^a   Ji, Yong Yong ^a   Lin, Ying ^a   Lin, Guo Mei ^a   Tian, Lin ^a   Wang, Jin ^c   Wang, Hong Xia ^c   Xie, You Hua ^a   Pei, Gang ^a   Wu, Jia Rui ^a   Sun, Bing ^a,d   more..

^a Chinese Academy of Sciences   (China)

^b Bioinformation Center   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d E institutes of Shanghai   (China)

Author keywords

Severe acute respiratory syndrome coronavirus; Spike protein; Syncytia formation and disease prevention; Synthetic peptide

Indexed keywords

CORONAVIRUS S PROTEIN; EPITOPE; PEPTIDE DERIVATIVE; PEPTIDE P10; PEPTIDE P6; PEPTIDE P8; PEPTIDE P9; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DESIGN; DRUG POTENCY; DRUG TARGETING; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SARS CORONAVIRUS; SEROLOGY; SYNCYTIUM;

CORONAVIRUS; SARS CORONAVIRUS; SARS COV;

EID: 20144389770     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.02.070     Document Type: Article

References (19)

1. C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H.R. Brodt, and S. Becker Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1967 1976
2. T.G. Ksiazek, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, and C. Urbani A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1947 1959
3. M.A. Marra, S.J. Jones, C.R. Astell, R.A. Holt, A. Brooks-Wilson, and Y.S. Butterfield The genome sequence of the SARS associated coronavirus Science 300 2003 1399 1404
4. Li Wenhui, Michael J. Moore, Vasilieva Natalya, and Sui Jianhua Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454
5. Xiao-Dong Wu, Bo Shang, Rui Fu Yang, Hao Yu, Zhi-Hai Ma, and Bing Sun The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells Cell Res. 14 5 2004 400 406
6. E.D. Qin, Q.Y. Zhu, M. Yu, B.C. Fan, G.H. Chang, and B.Y. Si A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01) Chin. Sci. Bull. 48 2003 941 948
7. X. Xiao, S. Chakraborti, A.S. Dimitrov, K. Gramatikoff, and D.S. Dimitrov The SARS-CoV S glycoprotein: expression and functional characterization Biochem. Biophys. Res. Commun. 312 4 2003 1159 1164
8. Ying Lin, Xu Shen, Rui Fu Yang, Yi Xue Li, Yong Yong Ji, and You Yu He Identification of an epitope of SARS-coronavirus nucleocapsid protein Cell Res. 13 3 2003 141 145
9. R. Zeng, R.F. Yang, M.D. Shi, and M.R. Jiang Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients J. Mol. Biol. 341 1 2004 271 279
10. Jianhua Sui, Wenhui Li, Akikazu Murakami, and Azaibi Tamin Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Proc. Natl. Acad. Sci. USA 101 2004 2536 2541
11. Yadi Wu, Wanqiu Hou, Yangping Wang, and Bing Sun IFN-γ up-regulation of IL-12β2 receptor expression was involved in the susceptibility to experimental autoimmune uveitis J. Neuroimmunol. 137 2003 145 153
12. Berend Jan Bosch, Byron E.E. Martina, Ruurd van der Zee, and Jean Lepault Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides Proc. Natl. Acad. Sci. USA 101 2004 8455 8460
13. T.Y. Ho, S.L. Wu, S.E. Cheng, Y.C. Wei, S.P. Huang, and C.Y. Hsiang Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein Biochem. Biophys. Res. Commun. 313 4 2004 938 947
14. J. Stavrinides, and D.S. Guttman Mosaic evolution of the severe acute respiratory syndrome coronavirus J. Virol. 78 1 2004 76 82
15. Leo L.M. Poon, Kwok Hung Chan, On Kei Wong, Wing Cheong Yam, Kwok Yang Yuen, and Yi Guan Early diagnosis of SARS coronavirus infection by real time RT-PCR J. Clin. Virol. 28 2003 233 238
16. M.K. Ijaz, T.O. Alkami, and A.W. El-Mekki Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4 Vaccine 13 1995 331 338
17. Saïd Taouji, Izumi Nomura, Steeve Giguère, and Seiji Tomomitsu Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi Vaccine 22 2004 1114 1123
18. Jingqiang Wang, Jie Wen, Jing Xiang Li, and Jianning Yin Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus Clin. Chem. 49 12 2004 1989 1996
19. S.K. Wong, W. Li, M.J. Moore, H. Choe, and M.A. Farzan 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 J. Biol. Chem. 279 5 2004 3197 3201